ENPP2 and obesity due to melanocortin 4 receptor deficiency: The effects of ATX have been shown to be systemic in diseases such as sepsis [49], obesity [50], idiopathic pulmonary fibrosis [51], chronic liver diseases [52], and in an autocrine [53,54]/paracrine manner in various cancers and rheumatoid arthritis [55,56].